Avalo Therapeutics Inc
F:C6K
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Avalo Therapeutics Inc
F:C6K
|
US |
|
Elanco Animal Health Inc
NYSE:ELAN
|
US |
|
I
|
Investec PLC
XMUN:IVKA
|
UK |
|
B
|
Bank of Montreal
SWB:BZZ
|
CA |
|
Nedbank Group Ltd
OTC:NDBKF
|
ZA |
|
S
|
Spirit AeroSystems Holdings Inc
F:S9Q
|
US |
|
PCI- PAL PLC
F:FVA
|
UK |
|
C
|
Credit Suisse Group AG
XHAM:CSX
|
CH |
|
M
|
Mitsubishi Kakoki Kaisha Ltd
TSE:6331
|
JP |
|
Banco de Sabadell SA
F:BDSB
|
ES |
|
C
|
Crown Castle Inc
SWB:8CW
|
US |
|
T
|
Teva Pharmaceutical Industries Ltd
SWB:TEV
|
IL |
|
Tenaris SA
F:TW10
|
LU |
|
J
|
Jones Lang LaSalle Inc
SWB:4J2
|
US |
|
C
|
Case Group AB
F:V9E
|
SE |
|
A
|
Avnet Inc
SWB:VNI
|
US |
|
H
|
HSBC Holdings PLC
OTC:HBCYF
|
UK |
|
T
|
Targa Resources Corp
XBER:TAR
|
US |
|
M
|
Marathon Petroleum Corp
F:MPN
|
US |
|
Nippon Television Holdings Inc
OTC:NPTVF
|
JP |
|
Agree Realty Corp
F:AGL
|
US |
Multiples-Based Value
The Multiples-Based Value for
Avalo Therapeutics Inc (C6K) under the Base Case is hidden
EUR.
Compared with the current market price of 2.488 EUR, the stock appears hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.